share_log

BTIG Maintains Buy on DermTech, Lowers Price Target to $2

Moomoo 24/7 ·  Mar 7 11:42

BTIG analyst Mark Massaro maintains DermTech (NASDAQ:DMTK) with a Buy and lowers the price target from $4 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment